Abiopharma

🔍 VisionWave Holdings, Inc. (Director)

Company: SaverOne 2014 Ltd. (SVRE)

Report Date: 2026-04-28

Detailed Transactions and Holdings:

• Acquired 1,080,000,000 shares of Ordinary Shares at $4.0 per share (Direct)
  Date: 2026-04-28 | Code: P | equity_swap_involved: 0 | shares_owned_after: 11,753,985,600.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 458,697,600 shares of Ordinary Shares at $4.0 per share (Direct)
  Date: 2026-04-29 | Code: P | equity_swap_involved: 0 | shares_owned_after: 12,212,683,200.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The price reported is the price per American Depositary Share ("ADS") acquired in an open-market transaction on The Nasdaq Stock Market LLC. Each ADS represents 43,200 ordinary shares of the Issuer pursuant to the ADS ratio effective February 25, 2026. The Reporting Person acquired 25,000 ADSs on April 28, 2026 at $4.00, and 10,618 ADSs on April 29, 2026 at $4.00, 1, resulting in the underlying ordinary shares reported.
• F2: The Reporting Person is deemed a director of the Issuer under Section 16(a) by deputization due to its designation and control over Douglas Davis, who serves on the Issuer's Board of Directors pursuant to rights granted under the Exchange Agreement dated January 26, 2026. Reflects beneficial ownership following the reported transactions. The Reporting Person has sole voting and dispositive power over these shares. No other equity securities or derivative securities of the Issuer are beneficially owned by the Reporting Person as of the date hereof, except as previously reported on Form filed April 2, 2026.